Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

GP-Act III Acquisition (GPAT) EBT (2023 - 2025)

GP-Act III Acquisition (GPAT) has disclosed EBT for 3 consecutive years, with $2.9 million as the latest value for Q4 2025.

  • Quarterly EBT fell 12.43% to $2.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $11.9 million through Dec 2025, up 37.13% year-over-year, with the annual reading at $11.9 million for FY2025, 37.13% up from the prior year.
  • EBT for Q4 2025 was $2.9 million at GP-Act III Acquisition, down from $3.1 million in the prior quarter.
  • The five-year high for EBT was $3.7 million in Q3 2024, with the low at -$59738.0 in Q1 2024.
  • Average EBT over 3 years is $1.9 million, with a median of $2.9 million recorded in 2025.
  • The sharpest move saw EBT surged 593680.68% in 2024, then dropped 15.06% in 2025.
  • GP-Act III Acquisition's EBT stood at -$12108.0 in 2023, then soared by 27390.2% to $3.3 million in 2024, then dropped by 12.43% to $2.9 million in 2025.
  • Per Business Quant, the three most recent readings for GPAT's EBT are $2.9 million (Q4 2025), $3.1 million (Q3 2025), and $3.0 million (Q2 2025).